Acquired syphilis in adults

New England Journal of Medicine

Volumn 326, Issue 16, 1992, Pages 1060-1069

  Hook, Edward W ^a   Marra, Christina M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; CD4 ANTIGEN; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; ERYTHROMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN G SODIUM; PROCAINE PENICILLIN; TETRACYCLINE;

ADULT; BLOOD TOXICITY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL FEATURE; DISEASE COURSE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HEALTH SERVICES RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; SYPHILIS; SYPHILIS SEROLOGY; TREPONEMA PALLIDUM;

ADULT; HIV INFECTIONS; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYPHILIS;

EID: 0027121632     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199204163261606     Document Type: Review

References (122)

1. Sparling P.F. Natural history of syphilis. In: Holmes KK, Mardh P-A, Sparling PF, et al. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990: 213-9.
2. Brandt A.M. No magic bullet: a social history of venereal disease in the United States since 1880. New York: Oxford University Press, 1987.
3. Division of STD/HIV Prevention. Sexually transmitted disease surveillance, 1990. Atlanta: Centers for Disease Control, 1991.
4. Blount J.H., Holmes K.K. Epidemiology of syphilis and the nonvenereal treponematoses. In: Johnson RC. The biology of parasitic spirochetes. New York: Academic Press, 1976: 157-76.
5. Primary and secondary syphilis — United States, 1981–1990. MMWR 1991; 40:314-323
6. Fleming W.L., Brown W.J., Donohue J.F., Branigin P.W. National survey of venereal disease treated by physicians in 1968. JAMA 1970:211:1827-1830
7. Brandt A.M. The syphilis epidemic and its relation to AIDS. Science 1988; 239:375-380
8. Hutchinson C.M., Hook E.W. III. Syphilis in adults. Med Clin North Am 1990; 74:1389-1416
9. Rolfs R.T., Nakashima A.K. Epidemiology of primary and secondary syphilis in the United States, 1981 through 1989. JAMA 1990:264:1432-1437
10. Handsfield H.H., Schwebke J. Trends in sexually transmitted diseases in homosexually active men in King County, Washington, 1980–1990. Sex Transm Dis 1990; 17:211-215
11. Congenital syphilis—New York City, 1986–1988. MMWR 1989; 38:825-829
12. Ricci J.M., Fojaco R.M., O#x0027;Sullivan M.J. Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986–1988. Obstet Gynecol 1989; 74:687-693
13. Minkoff H.L., McCalla S., Delke I., Stevens R., Salwen M., Feldman J. The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women. Am J Obstet Gynecol 1990; 163:521-526
14. Rolfs R.T., Goldberg M., Sharrar R.G. Risk factors for syphilis: cocaine use and prostitution. Am J Public Health 1990; 80:853-857
15. Farley T.A., Hadler J.L., Gunn R.A. The syphilis epidemic in Connecticut: relationship to drug use and prostitution. Sex Transm Dis 1990; 17:163-168
16. Andrus J.K., Fleming D.W., Harger D.R., et al. Partner notification: can it control epidemic syphilis? Ann Intern Med 1990; 112:539-543
17. Alternative case-finding methods in a crack-related syphilis epidemic —Philadelphia. MMWR 1991; 40:77-80.
18. Epidemic early syphilis — Escambia County, Florida, 1987 and July 1989—June 1990. MMWR 1991; 40:323-325
19. Thomburg R.W., Baseman J.B. Comparison of major protein antigens and protein profiles of Treponema pallidum and Treponema pertenue. Infect Immun 1983; 42:623-627
20. Baker-Zander S.A., Lukehart S.A. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue. Infect Immun 1983; 42:634-638
21. Miao R.M., Fieldsteel A.H. Genetic relationship between Treponema pallidum and Treponema pertenue, two noncultivable human pathogens. J Bacteriol 1980; 141:427-429
22. Smibert R.M. The spirochetes: family I genus III: Treponema. In: Kreig NR, Holt JG, eds. Bergey#x0027;s manual of systematic bacteriology. Vol. 1. Baltimore: Williams & Wilkins, 1984: 50.
23. Yobs A.R., Brown L., Hunter E.F. Fluorescent antibody technique in early syphilis: as applied to the demonstration of T. pallidum in lesions in the rabbit and in the human. Arch Pathol 1964; 77:220-225
24. Hook E.W. III, Roddy R.E., Lukehart S.A., Horn J., Holmes K.K., Tam M.R. Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody. J Clin Microbiol 1985; 22:241-244
25. Turner T.B., Hardy P.H., Neuman B. Infectivity tests in syphilis. Br J Vener Dis 1969; 45:183-196
26. Lukehart S.A., Hook E.W. III, Baker-Zander S.A., Collier A.C., Critchlow C.W., Handsfield H.H. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109:855-862
27. Noordhoek G.T., Cockayne A., Schouls L.M., Meloen R.H., Stolz E., Van Embden J.D.A. A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws. J Clin Microbiol 1990; 28:1600-1607
28. Erratum, J Clin Microbiol 1990; 28:2853.
29. Grimprel E., Sanchez P.J., Wendel G.D., et al. Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol 1991; 29:1711-1718
30. Sparling P.F. Diagnosis and treatment of syphilis. N Engl J Med 1971; 284: 642-53.
31. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986; 104:368-376
32. Moore J.E. The diagnosis of syphilis by the general practitioner. Washington, DC: Public Health Service Printing Office, 1949. (Publication no. 426, 1–68.)
33. Lefevre J.C., Bertrand M.A., Bauriaud R. Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol 1990; 28:1704-1707
34. Nelson K.E., Vlahov D., Cohn S., et al. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis 1991; 164:457-463
35. von Werssowetz A.J. The incidence of infection in contacts of early syphilis. J Vener Dis Inf 1948; 29:132-137
36. Moore M.B., Price E.V., Knox J.M., Elgin L.W. Epidemiologic treatment of contacts of infectious syphilis. Public Health Rep 1963; 78:966-970
37. Schroeter A.L., Turner R.H., Lucas J.B., Brown W.J. Therapy for incubating syphilis; effectiveness of gonorrhea treatment. JAMA 1971; 218:711-713
38. Schober P.C., Gabriel G., White P., Felton W.F., Thin R.N. How infectious is syphilis? Br J Vener Dis 1983; 59:217-219
39. Schrijvers D., Josse R., Trebucq A., Dupont A., Cheringou H., Larouzé B. Transmission of syphilis between sexual partners in Gabon. Genitourin Med 1989; 65:84-85
40. Magnuson H.J., Thomas E.W., Olansky S., Kaplan S.I., de Mello L., Cutler J.C. Inoculation syphilis in human volunteers. Medicine (Baltimore) 1956; 35: 33-82.
41. Simon R.P. Neurosyphilis. Arch Neural 1985; 42:606-613
42. Merritt H.H. The early clinical and laboratory manifestations of syphilis of the central nervous system. N Engl J Med 1940; 223:446-450
43. Mindel A., Tovey S.J., Timmins D.J., Williams P. Primary and secondary syphilis, 20 years#x0027; experience. 2. Clinical features. Genitourin Med 1989; 65:1-3.
44. Anderson J., Mindel A., Tovey S.J., Williams P. Primary and secondary syphilis, 20 years#x0027; experience. 3. Diagnosis, treatment, and follow up. Genitourin Med 1989; 65:239-243
45. Stokes J.H., Beerman H., Ingraham N.R. Modern clinical syphilology: diagnosis, treatment, case study. 3rd ed. Philadelphia: W.B. Saunders, 1944.
46. Clark E.G., Danbolt N. The Oslo study of the natural course of untreated syphilis: an epidemiologic investigation based on a re-study of the Boeck-Bruusgaard material. Med Clin North Am 1964; 48:613-623
47. Hira S.K., Patel J.S., Bhat S.G., Chilikima K., Mooney N. Clinical manifestations of secondary syphilis. Int J Dermatol 1987; 26:103-107
48. Chapel T.A. The signs and symptoms of secondary syphilis. Sex Transm Dis 1980; 7:161-164
49. Parker J.D.J. Uncommon complications of early syphilis: hepatitis, periostitis, iritis with papillitis, and meningitis. Br J Vener Dis 1972; 48:32-36
50. Kampmeier R.H. The late manifestations of syphilis: skeletal, visceral and cardiovascular. Med Clin North Am 1964; 48:667-697
51. Olansky S. Late benign syphilis (gumma). Med Clin North Am 1964; 48:653-665
52. Jackman J.D. Jr., Radolf J.D. Cardiovascular syphilis. Am J Med 1989; 87:425-433
53. Diaz-Mitoma F., Benningen G., Slutchuk M., Ronald A.R., Brunham R.C. Etiology of nonvesicular genital ulcers in Winnipeg. Sex Transm Dis 1987; 14:33-36
54. Wile U.J., Hasley C.K. Involvement of nervous system during primary stage of syphilis. JAMA 1921; 76:8-9.
55. Mills C.H. Routine examination of the cerebrospinal fluid in syphilis: its value in regard to more accurate knowledge, prognosis, and treatment. BMJ 1927; 2:527-532
56. Ravaut P. Le liquide céphalo-rachidien des syphilitiques en période secondaire. Ann Dermatol Syphiligr 1903; 4:537-554
57. Wile U.J., Stokes J.H. A study of the spinal fluid with reference to involvement of the nervous system in secondary syphilis. J Cutan Dis 1914; 32: 607-23.
58. Moore J.E. Studies in asymptomatic neurosyphilis. II. The classification, treatment, and prognosis of early asymptomatic neurosyphilis. Bull Johns Hopkins Hosp 1922; 33:231-246
59. Chesney A.M., Kemp J.E. Incidence of Spirochaeta pallida in cerebrospinal fluid during early stage of syphilis. JAMA 1924; 83:1725-1728
60. Hahn R.D., Clark E.G. Asymptomatic neurosyphilis: a review of the literature. Am J Syph Gonorrhea Vener Dis 1946; 30:305-316
61. Moore J.E., Hopkins H.H. Asymptomatic neurosyphilis. VI. The prognosis of early and late asymptomatic neurosyphilis. JAMA 1930; 95:1637-1641
62. Merritt H.H., Adams R.D., Solomon H.C. Neurosyphilis. New York: Oxford University Press, 1946.
63. Burke J.M., Schaberg D.R. Neurosyphilis in the antibiotic era. Neurology 1985; 35:1368-1371
64. Hotson J.R. Modern neurosyphilis: a partially treated chronic meningitis. West J Med 1981; 135:191-200.
65. Izzat N.N., Bartruff J.K., Glicksman J.M., Holder W.R., Knox J.M. Validity of the VDRL test on cerebrospinal fluid contaminated by blood. Br J Vener Dis 1971; 47:162-164
66. Davis L.E., Sperry S. The CSF-FTA test and the significance of blood contamination. Ann Neurol 1979; 6:68-69
67. Jaffe H.W., Larsen S.A., Peters M., Jove D.F., Lopez B., Schroeter A.L. Tests for treponemal antibody in CSF. Arch Intern Med 1978; 138:252-255
68. David L.E., Schmitt J.W. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989; 25:50-55
69. Eagle H. Speculations as to the therapeutic significance of the penicillin blood level. Ann Intern Med 1948; 28:260-278
70. Magnuson H.J., Eagle H., Fleischman R. The minimal infectious inoculum of Spirochaeta paluda (Nichols strain), and a consideration of its rate of multiplication in vivo. Am J Syph Gonorrhea Vener Dis 1948; 32:1-18.
71. Yobs A.R., Rockwell D.H., Clark J.W. Jr. Treponemal survival in humans after penicillin therapy: a preliminary report. Br J Vener Dis 1964; 40:248-253
72. Collart P., Borel L.-J., Durel P., et al. Significance of spiral organisms found, after treatment, in late human and experimental syphilis. Br J Vener Dis 1964; 40:81-89
73. Rein M.F. Biopharmacology of syphilotherapy. J Am Vener Dis Assoc 1976; 3:109-127
74. Idsφe O., Guthe T., Willcox R.R. Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Organ 1972; 47:Suppl:l-68.
75. Schroeter A.L., Lucas J.B., Price E.V., Falcone V.H. Treatment for early syphilis and reactivity of serologic tests. JAMA 1972; 221:471-476
76. Sexually transmitted diseases treatment guidelines. MMWR 1989; 38: Suppl 8:1-13.
77. Erratum, MMWR 1989; 38:664.
78. Kampmeier R.H. The introduction of penicillin for the treatment of syphilis. Sex Transm Dis 1981; 8:260-265
79. Mohr J.A., Griffiths W., Jackson R., Saadah H., Bird P., Riddle J. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236:2208-2209
80. van der Valk P.G.M., Kraai E.J., van Voorst Vader P.C., Haaxma-Reiche H., Snijder J.A.M. Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis. Genitourin Med 1988; 64:223-225
81. Tramont E.C. Persistence of Treponema pallidum following penicillin G therapy: report of two cases. JAMA 1976; 236:2206-2207
82. Bayne L.L., Schmidley J.W., Goodin D.S. Acute syphilitic meningitis: its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch Neurol 1986; 43:137-138
83. Markovitz D.M., Beutner K.R., Maggio R.P., Reichman R.C. Failure of recommended treatment for secondary syphilis. JAMA 1986; 255:1767-1768
84. Johns D.R., Tierney M., Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316:1569-1572
85. Musher D.M., Hamill R.J., Baughn R.E. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990; 113:872-881
86. Goh B.T., Smith G.W., Samarasinghe L., Singh V., Lim K.S. Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin O.6 MU with and without probenecid. Br J Vener Dis 1984; 60:371-373
87. Schoth P.E.M., Wolters E.C.H. Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology 1987; 37:1214-1216
88. Stapleton J.T., Stamm L.V., Bassford P.J. Jr. Potential for development of antibiotic resistance in pathogenic treponemes. Rev Infect Dis 1985; 7: Suppl 2:S314-S317.
89. Norgard M.V., Miller J.N. Plasmid DNA in Treponema pallidum (Nichols): potential for antibiotic resistance by syphilis bacteria. Science 1981; 213: 553-5.
90. Hashisaki P., Wertzberger G.G., Conrad G.L., Nichols C.R. Erythromycin failure in the treatment of syphilis in a pregnant woman. Sex Transm Dis 1983; 10:36-38
91. Duncan W.C., Knox J.M. Cephalexin therapy for infectious syphilis. Arch Dermatol 1974; 110:77-80.
92. Nicolis G., Loucopoulos A. Cephalothin in the treatment of syphilis. Br J Vener Dis 1974; 50:270-271
93. Moorthy T.T., Lee C.-T., Lim K.-B., Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex Transm Dis 1987; 14: 116-8.
94. Hook E.W. III, Roddy R.E., Handsfield H.H. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988; 158:881-884
95. Onoda Y. Clinical evaluation of amoxycillin in the treatment of syphilis. J Int Med Res 1979; 7:539-545
96. Roy R., Ghosh S. Chloramphenicol in syphilis. J Indian Med Assoc 1963; 40:498-501.
97. Gruhzit O.M., Fisken R.A. Chloramphenicol (chloromycetin) in experimental syphilis in rabbits. Am J Syph 1950; 34:338-341
98. Romanowski B., Sutherland R., Fick G.H., Mooney D., Love E.J. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114: 1005-9.
99. Brown S.T., Zaidi A., Larsen S.A., Reynolds G.H. Serological response to syphilis treatment: a new analysis of old data. JAMA 1985; 253:1296-1299
100. Fiumara N.J. Reinfection primary, secondary, and latent syphilis: the seralogic response after treatment. Sex Transm Dis 1980; 7:111-115
101. Hahn R.D., Cutler J.C., Curtis A.C., et al. Penicillin treatment of asymptomatic central nervous system syphilis. Arch Dermatol 1956; 74:367-377
102. Hook E.W. III. Syphilis and HIV infection. J Infect Dis 1989; 160:530-534
103. Quinn T.C., Cannon R.O., Glasser D., et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990; 150:1297-1302
104. Cameron D.W., Simonsen J.N., D#x0027;Costa L.J., et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2:403-407
105. Stamm W.E., Handsfield H.H., Rompalo A.M., Ashley R.L., Roberts P.L., Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-1433
106. Darrow W.W., Echenberg D.F., Jaffe H.W., et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am J Public Health 1987; 77:479-483
107. Kreiss J.K., Coombs R., Plummer F., et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160:380-384
108. Radolf J.D., Kaplan R.P. Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 1988; 18:Suppl:423-428
109. Katz D.A., Berger J.R. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 1989; 46:895-898
110. McLeish W.M., Pulido J.S., Holland S., Culbertson W.W., Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology 1990; 97:196-203.
111. Hutchinson C.M., Rompalo A.M., Reichart C.A., Hook E.W. III. Characteristics of patients with syphilis attending Baltimore STD clinics: multiple, high-risk subgroups and interactions with human immunodeficiency virus infection. Arch Intern Med 1991; 151:511-516
112. Lukehart S.A., Baker-Zander S.A., Lloyd R.M.C., Sell S. Effect of cortisone administration on host-parasite relationships in early experimental syphilis. J Immunol 1981; 127:1361-1368
113. Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR 1988; 37:600-608
114. Hicks C.B., Benson P.M., Lupton G.P., Tramont E.C. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma: a diagnostic dilemma. Ann Intern Med 1987; 107:492-495
115. Erratum, Ann Intern Med 1987; 107: 946.
116. Haas J.S., Bolan G., Larsen S.A., Clement M.J., Bacchetti P., Moss A.R. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis 1990; 162:862-866
117. Johnson P.D.R., Graves S.R., Stewart L., Warren R., Dwyer B., Lucas C.R. Specific Syphilis serological tests may become negative in HIV infection. AIDS 1991; 5:419-423
118. Gregory N., Sanchez M., Buchness M.R. The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1990; 22:1061-1067
119. Tikjob G., Russel M., Petersen C.S., Gerstoft J., Kobayasi T. Seronegative secondary syphilis in a patient with AIDS: identification of Treponema pallidum in a biopsy specimen. J Am Acad Dermatol 1991; 24:506-508
120. Berry C.D., Hooton T.M., Collier A.C., Lukehart S.A. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316:1587-1589
121. Rompalo A.M., Cannon R.O., Quinn T.C., Hook E.W. III. The association of biologic false positive serologic test results for syphilis with HIV infection. J Infect Dis (in press).
122. Telzak E.E., Greenberg M.S.Z., Harrison J., Stonebumer R.L., Schultz S. Syphilis treatment response in HIV-infected individuals. AIDS 1991; 5: 591-5.